OT
Healthcare & Life Sciences

Outlook Therapeutics

Outlook Therapeutics is a Healthcare & Life Sciences startup based in the United States, 1 tracked investor.

Active
1
Investors

About Outlook Therapeutics

Outlook Therapeutics is a startup based in the United States. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Outlook Therapeutics develops and commercializes ophthalmic therapies for retinal diseases, including FDA-approved LYTENAVA, a bevacizumab formulation for neovascular (wet) age-related macular degeneration.

Explore Outlook Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States